Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.

Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.

Blueberry Therapeutics will use the proceeds from the $12.8m China Medical System-backed round to advance its skin and nail infection treatments.

Immunotherapy developer Biontech has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.

University of Aberdeen and entrepreneurial training firm Elevator have concluded the latest edition of their Accelerator Aberdeen program.

Two corporate players backed gene therapeutics firm Orchard Therapeutics in a round that may indicate an uptick in investments in genetics-related tech for this year

Digital prescription platform Healthera has been backed by Cambridge Enterprise, its Seed Funds vehicle and UCEF.